Skip to main navigation
  • About SIGA
  • Products
  • Investors
    • Press Releases
    • Events & Presentations
    • Financial Information
      • SEC Filings
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
      • Contact the Board
      • Contact Audit Committee
    • Stock Information
    • Investor FAQs
    • Investor Contact
  • News
  • Careers
  • Contact

SIGA: Human BioArmor

Providing solutions for unmet needs in health security
  • About SIGA
  • Products
  • Investors
  • News
  • Careers
  • Contact

Press Release Details

Investors
  • Press Releases
  • Events & Presentations
  • Financial Information
    • SEC Filings
  • Corporate Governance
    • Management
    • Board of Directors
    • Committee Composition
    • Contact the Board
    • Contact Audit Committee
  • Stock Information
  • Investor FAQs
  • Investor Contact

Tove’ Bolken shares perspective on what biopharmaceutical companies can expect in manufacturing for 2021 and beyond

November 30, 2020 at 12:00 PM EST
Tove’ Bolken shares perspective on what biopharmaceutical companies can expect …

Latest Press Releases

Mar 23, 2021
Cipla Therapeutics and SIGA Technologies Announce Strategic Partnership to support innovation and provide access to novel antibacterial drugs against biothreats
Mar 04, 2021
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2020
Feb 26, 2021
SIGA Technologies to Host Business Update Call on March 4, 2021 Following Release of Year End 2020 Financial Results

Shareholder Tools

Print
Email Alerts
RSS News Feeds
Contact IR

SIGA: Human BioArmor

  • Corporate Headquarters
    31 East 62nd Street
    New York, NY 10065
    (212) 672-9100

  • SIGA Development Operations
    4575 SW Research Way, Suite 110
    Corvallis, OR 97333
    (541) 753-2000

  • Privacy Policy

© SIGA Technologies, All Rights Reserved